---
title: "Executive Summary"
description: "Index of executive summary resources"
published: true
date: '2026-01-15T23:52:27.487Z'
permalink: "/reference/cost-barriers/executive-summary/"
---

# Executive Summary

## Pages

- [Clinical Trial Decision-making Model](./e1-clinical-trial-decision-making-model.md)
- [Clinical Trial Cost Analysis by Therapeutic Area and Phase](./e2-analysis-of-costs.md)
- [Barriers to Clinical Trials in the United States](./e3-barriers-to-clinical-trials.md)
- [High Financial Costs in Drug Development](./e31-high-financial-cost.md)
- [Lengthy Timelines in Clinical Trials](./e32-lengthy-timelines.md)
- [Difficulties in Recruiting and Retaining Clinical Trial Participants](./e33-difficulties-in-recruiting-and-retaining-participants.md)
- [Increasing Competition for Qualified Investigators and Sites](./e34-increasing-competition-for-qualified-investigators-and-sites.md)
- [Regulatory and Administrative Barriers in Clinical Research](./e35-regulatory-and-administrative-barriers.md)
- [Drug Sponsor-Imposed Barriers in Clinical Trials](./e36-drug-sponsor-imposed-barriers.md)
- [Disconnect Between Clinical Research and Medical Care](./e37-disconnect-between-clinical-research-and-medical-care.md)
- [Barriers to Clinical Trials at Academic Institutions](./e38-barriers-at-academic-institutions.md)
- [Barriers in Global Clinical Research](./e39-barriers-related-to-the-globalization-of-clinical-research.md)
- [Barriers to Clinical Trials and Mitigation Strategies](./e4-analysis-of-barriers-to-clinical-trials.md)

